1-6 of 6
Fabio Guolo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Elisa Gelli, Giulia Giorgetti, Claudia Martinuzzi, Francesco Piacente, Dr, Luca Mastracci, Claudia Veneziano, Dr, Gianluca Santamaria, Dr, Fiammetta Monacelli, Moustafa S Ghanem, Antonia Cagnetta, Fabio Guolo, Dr, Matteo Garibotto, Sara Aquino, Mario Passalacqua, Santina Bruzzone, Axel Bellotti, Michel A. Duchosal, Aimable A Nahimana, Emanuele Angelucci, Chandra Nagasuma, Prof, Alessio Nencioni, Roberto Massimo Lemoli, Michele Cea, Prof
Journal: Blood Advances
Blood Adv bloodadvances.2024013425.
https://doi.org/10.1182/bloodadvances.2024013425
Published: 2024
Includes: Supplemental data
Journal Articles

Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS

Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahmé, Sarah Bertoli, Luana Fianchi, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Olivier Legrand, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Leon Caulier, Michelina Dargenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christian Récher, Francesco Grimaldi, Lionel Adès, Roberto Massimo Lemoli
Journal: Blood Advances
Blood Adv bloodadvances.2024014279.
https://doi.org/10.1182/bloodadvances.2024014279
Published: 2024
Journal Articles

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

Elisa Gelli, Debora Soncini, Pamela Becherini, Claudia Martinuzzi, Katia Todoerti, Antonia Cagnetta, Sara Aquino, Fabio Guolo, Maurizio Miglino, Santina Bruzzone, Alessio Nencioni, Antonino Neri, Roberto M. Lemoli, Michele Cea
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3472–3478.
https://doi.org/10.1182/bloodadvances.2022009035
Published: 2023
Includes: Supplemental data
Journal Articles

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph + acute lymphoblastic leukemia

Clinical Trials & Observations
Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. Lemoli, Fabio Guolo, Antonella Fornaro, Monia Lunghi, Paolo de Fabritiis, Anna Candoni, Carmine Selleri, Federico Simonetti, Monica Bocchia, Antonella Vitale, Luca Frison, Alessandra Tedeschi, Antonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’Ardia, Silvia Trappolini, Patrizia Tosi, Piero Galieni, Francesco Fabbiano, Maria Chiara Abbenante, Muriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara Sartor, Stefania Paolini, Michele Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Michele Baccarani
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1742–1753.
https://doi.org/10.1182/bloodadvances.2021004821
Published: 2022
Journal Articles

Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey

Caterina Giovanna Valentini, Alfonso Piciocchi, Fabio Facchetti, Fabio Guolo, Alessandro Pulsoni, Marco Vignetti, Livio Pagano
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5608–5611.
https://doi.org/10.1182/bloodadvances.2021005802
Published: 2021
Journal Articles

Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death

Debora Soncini, Paola Minetto, Claudia Martinuzzi, Pamela Becherini, Valeria Fenu, Fabio Guolo, Katia Todoerti, Giovanni Calice, Paola Contini, Maurizio Miglino, Giulia Rivoli, Sara Aquino, Alida Dominietto, Antonia Cagnetta, Mario Passalacqua, Santina Bruzzone, Alessio Nencioni, Massimo Zucchetti, Tommaso Ceruti, Antonino Neri, Roberto M. Lemoli, Michele Cea
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4312–4326.
https://doi.org/10.1182/bloodadvances.2020001639
Published: 2020
Includes: Supplemental data